Safety of Botulinum Toxin A in Children and Adolescents with Cerebral Palsy in a Pragmatic Setting

This retrospective study aimed to examine the safety of botulinum toxin A (BoNT-A) treatment in a paediatric multidisciplinary cerebral palsy clinic. In a sample of 454 patients who had 1515 BoNT-A sessions, data on adverse events were available in 356 patients and 1382 sessions; 51 non-fatal advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Papavasiliou, Antigone S., Nikaina, Irene, Foska, Katerina, Bouros, Panagiotis, Mitsou, George, Filiopoulos, Constantine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705276/
https://www.ncbi.nlm.nih.gov/pubmed/23482250
http://dx.doi.org/10.3390/toxins5030524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705276/
https://www.ncbi.nlm.nih.gov/pubmed/23482250
http://dx.doi.org/10.3390/toxins5030524

Ejemplares similares